Clinical Trial Update: Clinical Study of TCR-like CAR-T Cell Targeted MSLN in the Treatment of Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study of TCR-like CAR-T cells targeting mesothelin in ovarian cancer; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• TCR-like CAR-T cell targeted MSLN (TCR-like CAR-T cell targeting mesothelin)

Snippet

Sponsor: Zhongda Hospital | Conditions: Safety and Efficacy of TCR-like CAR-T | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING